Clinical trial
Prophylactic Annti-fungal Treatment in Severe Sepsis Patients With Perforations in SICU
NCT02941068 is registered in ClinicalTrials.gov with Nanjing PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Annti-fungal Treatment in Severe Sepsis Patients With Perforations in SICU
- Lead sponsor
- Nanjing PLA General Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- Not reported
- Enrollment
- 223 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
intra-abdominal perforation